| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/22/2004 | US6753149 For producing vaccines for the prevention or attenuation of infection by staphylococcus |
| 06/22/2004 | US6753140 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 06/22/2004 | US6753136 Expressing preferential amino acid sequences on surface of viruses; obtain genetically engineered viruses, express amino acid sequences, moniltor viral coat for presence of preferential amino acid sequences |
| 06/22/2004 | US6752996 Adjuvant for poorly immunogenic tumor vaccines and subunit vaccines, such as those for preventing and/or treating flu, tuberculosis, respiratory syncytial virus, anthrax and hiv. |
| 06/22/2004 | US6752995 Nucleic acid and polypeptide sequences useful as adjuvants |
| 06/22/2004 | US6752994 Microorganismal cell model for use as tool in treatment of tuberculosis, skin disorders and infections |
| 06/22/2004 | US6752993 Abundant extracellular product vaccines and methods for their production and use |
| 06/22/2004 | US6752992 Bacillus endotoxin for controlling moths; cry proteins |
| 06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
| 06/22/2004 | US6752987 Adenovirus encoding human adenylylcyclase (AC) VI |
| 06/22/2004 | CA2164672C Process for purifying hepatitis b viral surface antigen comprising pres2 peptide |
| 06/22/2004 | CA2117904C Methods and reagents for diagnosis of autoantibodies |
| 06/22/2004 | CA2110702C Process for the production of a viable cell culture infected by a multiple sclerosis associated virus |
| 06/20/2004 | CA2453723A1 Method for increasing protein content in plant cells |
| 06/19/2004 | CA2411264A1 Sequences for detection and identification of the human metapneumovirus |
| 06/17/2004 | WO2004051269A2 Ciz1 replication protein |
| 06/17/2004 | WO2004051222A2 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases |
| 06/17/2004 | WO2004050900A2 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 06/17/2004 | WO2004050886A1 Packaging cell system for eb virus vector |
| 06/17/2004 | WO2004050883A2 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine |
| 06/17/2004 | WO2004050881A2 A plant transcription factor that is involved in sugar signalling |
| 06/17/2004 | WO2004050880A2 Insecticidal agent |
| 06/17/2004 | WO2004050876A1 A recombinant adenovirus relating gene vaccine used to therapy and prevent alzheimers disease, and use thereof |
| 06/17/2004 | WO2004050873A1 Genetically modified plants expressing proteinase inhibitors, sapina2a or sapin2b, and methods of use thereof for the inhibition of trypsin-and chymotrypsin-like activities |
| 06/17/2004 | WO2004050869A1 PROTEIN BINDING TO Akt2 |
| 06/17/2004 | WO2004050868A1 Novel adaptor protein binding to mammalian toll-like receptor 3 and gene thereof |
| 06/17/2004 | WO2004050864A1 Culture chamber for biologicals |
| 06/17/2004 | WO2004050860A2 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 06/17/2004 | WO2004050858A2 Compositions, splice variants and methods relating to colon specific genes and proteins |
| 06/17/2004 | WO2004050857A2 Splice variant of human sodium iii channel (hnaiii18) |
| 06/17/2004 | WO2004050856A2 Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methods |
| 06/17/2004 | WO2004050853A2 Uses of the snorf55 receptor |
| 06/17/2004 | WO2004050852A2 Recombinant polypeptides for diagnosing infection with trypanosoma cruzi |
| 06/17/2004 | WO2004050851A2 Prion protein ligands and methods of use |
| 06/17/2004 | WO2004050849A2 Recombinant immunotoxin and use in treating tumors |
| 06/17/2004 | WO2004050843A2 Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making |
| 06/17/2004 | WO2004050834A2 GPC99 AND GPC99a: METHODS AND COMPOSITIONS FOR TREATING CANCER |
| 06/17/2004 | WO2004050832A2 Antimicrobial compounds from bacillus subtilis for use against animal and human pathogens |
| 06/17/2004 | WO2004050829A2 Recombinant double-stranded rna phage, and use of the same |
| 06/17/2004 | WO2004050711A2 Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
| 06/17/2004 | WO2004050706A2 Regulatory t-cells |
| 06/17/2004 | WO2004050705A2 Complexes of receptors |
| 06/17/2004 | WO2004050704A1 Therapeutic and diagnostic agents |
| 06/17/2004 | WO2004050703A1 Splice variant of the human pituitary growth hormone |
| 06/17/2004 | WO2004050702A2 Novel ifngamma-like polypeptides |
| 06/17/2004 | WO2004050701A1 Bone growth factor |
| 06/17/2004 | WO2004050699A1 Structure of a complex of retinoblastoma protein bound to e2f, and uses thereof |
| 06/17/2004 | WO2004050698A2 Peptide conjugate useful for cell nucleus molecular imaging and tumor therapy |
| 06/17/2004 | WO2004050697A1 Bcl-w structure and uses therefor |
| 06/17/2004 | WO2004050696A2 Antimicrobial polypeptide isolated from rhizomucor pusillus |
| 06/17/2004 | WO2004050694A1 Methods for the production of methionine |
| 06/17/2004 | WO2004050693A1 Engineering redox proteins |
| 06/17/2004 | WO2004050692A2 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production |
| 06/17/2004 | WO2004050679A2 Mutant glycoproteins |
| 06/17/2004 | WO2004050672A2 Process for the extraction and isolation of insulin from recombinant sources |
| 06/17/2004 | WO2004050125A1 Inhibitor of proliferation and/or infiltration of tumor cells |
| 06/17/2004 | WO2004050124A2 Chimaeric molecules |
| 06/17/2004 | WO2004050119A1 Vaccine against enteropathogenic and enterohaemorragic escherichia coli |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050114A1 Novel agent for improving neurotransmission failure |
| 06/17/2004 | WO2004050113A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE |
| 06/17/2004 | WO2004050111A2 Methods and materials for treating inflammatory conditions using a polypeptide comprising a self-c5 amino acid segment and a non-self amino acid segment |
| 06/17/2004 | WO2004050017A2 Rationally designed antibodies |
| 06/17/2004 | WO2004044003A3 Use of edg2 receptor in an animal model of heart failure |
| 06/17/2004 | WO2004035775A3 Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mammal obtained by implementing said method and said mammal's progeny |
| 06/17/2004 | WO2004031233A9 Novel chemokine-like polypeptides |
| 06/17/2004 | WO2004029089A3 Novel angiogenesis target and uses thereof |
| 06/17/2004 | WO2004016738A3 Method and composition for treating and preventing hepatitis c infection |
| 06/17/2004 | WO2004015396A3 Cell adhesion and extracellular matrix proteins |
| 06/17/2004 | WO2004011677A3 Viral marker |
| 06/17/2004 | WO2004011609A3 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 06/17/2004 | WO2004011098A3 Golf shaft with adjustable stiffness and frequency |
| 06/17/2004 | WO2004009763A3 Use of vaccinia virus deleted for the e3l gene as a vaccine vector |
| 06/17/2004 | WO2004003133A3 Pain signaling molecules |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003105763A3 Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof |
| 06/17/2004 | WO2003098225A3 In vitro bioassay for determining the activity of glycoprotein hormones |
| 06/17/2004 | WO2003087145A3 Purified polypeptides involved in quorum sensing |
| 06/17/2004 | WO2003075831A3 NOVEL p53BP2 COMPOUNDS FOR THERAPY AND DIAGNOSIS AND METHODS FOR USING SAME |
| 06/17/2004 | WO2003064992A3 Novel immunoadhesins for treating and preventing toxicity and pathogen-mediated diseases |
| 06/17/2004 | WO2003063770A9 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/17/2004 | WO2003053997A3 Methods of increasing endogenous erythropoietin (epo) |
| 06/17/2004 | WO2003053334A3 Compositions and methods for the diagnosis and treatment of tumor |
| 06/17/2004 | WO2003051911A3 Gmg-5 polynucleotides and polypeptides and uses thereof |
| 06/17/2004 | WO2003050259A3 Nucleic acids related to plant retroelements |
| 06/17/2004 | WO2003048305A3 Receptors and membrane-associated proteins |
| 06/17/2004 | WO2003042235A3 Extended native chemical ligation of three or more peptide fragments |
| 06/17/2004 | WO2003032810A3 Treatment and diagnosis of insulin resistant states |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | WO2003023007A8 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39 |
| 06/17/2004 | WO2003018632A3 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 06/17/2004 | WO2003006673A3 A nucleic acid encoding a human junctional adhesion protein (jam3) |
| 06/17/2004 | WO2003000862A3 Homeotic genes and proteins, and uses thereof |
| 06/17/2004 | WO2002086443A8 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 06/17/2004 | US20040117874 Genetic engineering; Dna construct with signal sequence |
| 06/17/2004 | US20040117872 Expression vector comprising nucleotide sequences coding arogenate dehydrogenase for transformation and propagation of glyphosate resistant plants |
| 06/17/2004 | US20040117868 Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same |
| 06/17/2004 | US20040117867 Zebrafish animal models for clarifying gene function relationships in hyperproliferative disorders; antisense agents; RNA interference and tumor treatment therapies |
| 06/17/2004 | US20040117866 Novel transgenic zebrafish, gene fragments and methods for producing transgenic zebrafish |
| 06/17/2004 | US20040117864 Stable transgenic cells comprising functional neuronal protein; gene transfer and pattern analysis; insect model for monitoring cancer signal transduction |